Tasly Biopharmaceuticals Co. Ltd. 13D and 13G filings for I-Mab:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:01 pm Purchase | 2020-12-31 | 13G | I-Mab IMAB | Tasly Biopharmaceuticals Co. Ltd. | 13,655,240 8.300% | 13,655,240 (New Position) | Filing |